On-demand webcast from a live CCO webinar capturing global perspectives from Drs. Edward S. Kim and Luis Paz-Ares on the optimal management of patients with EGFR+ NSCLC
David Planchard, MD, PhD, discusses barriers to osimertinib access worldwide and future directions for the management of advanced EGFR-mutated NSCLC.
On-demand webcast from CCO where clinical experts discuss how to optimally integrate the latest clinical data on predictive biomarkers to guide treatment decisions in advanced NSCLC
In this on-demand webcast from CCO, Mary Jo Fidler, MD, and Scott Gettinger, MD, review the latest advances in immunotherapy for NSCLC through discussion of a series of patient cases.